1. Home
  2. AVDL vs CNOB Comparison

AVDL vs CNOB Comparison

Compare AVDL & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • CNOB
  • Stock Information
  • Founded
  • AVDL 2015
  • CNOB 1982
  • Country
  • AVDL Ireland
  • CNOB United States
  • Employees
  • AVDL N/A
  • CNOB N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • CNOB Major Banks
  • Sector
  • AVDL Health Care
  • CNOB Finance
  • Exchange
  • AVDL Nasdaq
  • CNOB Nasdaq
  • Market Cap
  • AVDL 1.5B
  • CNOB 1.3B
  • IPO Year
  • AVDL 1996
  • CNOB 1996
  • Fundamental
  • Price
  • AVDL $14.35
  • CNOB $25.63
  • Analyst Decision
  • AVDL Strong Buy
  • CNOB Buy
  • Analyst Count
  • AVDL 8
  • CNOB 1
  • Target Price
  • AVDL $20.88
  • CNOB $31.00
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • CNOB 322.5K
  • Earning Date
  • AVDL 11-11-2025
  • CNOB 10-23-2025
  • Dividend Yield
  • AVDL N/A
  • CNOB 2.74%
  • EPS Growth
  • AVDL N/A
  • CNOB N/A
  • EPS
  • AVDL N/A
  • CNOB 0.80
  • Revenue
  • AVDL $221,075,000.00
  • CNOB $241,854,000.00
  • Revenue This Year
  • AVDL $64.56
  • CNOB $50.62
  • Revenue Next Year
  • AVDL $30.60
  • CNOB $28.54
  • P/E Ratio
  • AVDL N/A
  • CNOB $32.98
  • Revenue Growth
  • AVDL 132.35
  • CNOB N/A
  • 52 Week Low
  • AVDL $6.38
  • CNOB $20.61
  • 52 Week High
  • AVDL $16.66
  • CNOB $29.31
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 43.90
  • CNOB 54.11
  • Support Level
  • AVDL $14.85
  • CNOB $24.90
  • Resistance Level
  • AVDL $15.58
  • CNOB $26.06
  • Average True Range (ATR)
  • AVDL 0.48
  • CNOB 0.61
  • MACD
  • AVDL -0.26
  • CNOB -0.01
  • Stochastic Oscillator
  • AVDL 12.16
  • CNOB 48.87

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: